419 | Humans |
367 | Coronavirus Infections |
320 | Pneumonia, Viral |
239 | Betacoronavirus |
148 | China |
132 | Animals |
114 | Disease Outbreaks |
91 | Female |
81 | Male |
61 | Adult |
55 | Middle Aged |
54 | SARS Virus |
48 | Severe Acute Respiratory Syndrome |
48 | Pandemics |
46 | Travel |
38 | Coronavirus |
37 | Public Health |
37 | Aged |
34 | Middle East Respiratory Syndrome Coronavirus |
32 | Antiviral Agents |
31 | Genome, Viral |
30 | Lung |
29 | Global Health |
29 | Child |
28 | Phylogeny |
27 | Young Adult |
27 | Antibodies, Viral |
24 | Zoonoses |
23 | Tomography, X-Ray Computed |
22 | Fever |
22 | Adolescent |
21 | Infection Control |
19 | World Health Organization |
19 | Risk Factors |
19 | Retrospective Studies |
19 | Respiratory Tract Infections |
19 | Infant |
19 | Child, Preschool |
18 | Viral Proteins |
18 | Spike Glycoprotein, Coronavirus |
18 | Republic of Korea |
18 | Chiroptera |
17 | Virus Diseases |
17 | United States |
17 | Time Factors |
17 | Radiography, Thoracic |
17 | Mice |
17 | Cough |
16 | Population Surveillance |
16 | Communicable Diseases, Emerging |
16 | Cattle |
15 | Aged, 80 and over |
14 | Virus Replication |
14 | Peptidyl-Dipeptidase A |
14 | Infant, Newborn |
14 | Coronaviridae |
14 | Amino Acid Sequence |
13 | Viral Vaccines |
13 | Viral Envelope Proteins |
13 | RNA, Viral |
12 | Rats |
12 | Pneumonia |
12 | Health Personnel |
12 | Europe |
12 | Epidemics |
12 | Disease Reservoirs |
12 | Contact Tracing |
12 | Cattle Diseases |
11 | Saudi Arabia |
11 | Reverse Transcriptase Polymerase Chain Reaction |
11 | Real-Time Polymerase Chain Reaction |
11 | Practice Guidelines as Topic |
11 | Patient Isolation |
11 | Influenza, Human |
11 | Coronaviridae Infections |
10 | Sequence Alignment |
10 | Polymerase Chain Reaction |
10 | Mass Screening |
10 | Delivery of Health Care |
9 | Severity of Illness Index |
9 | Sensitivity and Specificity |
9 | Risk Assessment |
9 | Prognosis |
9 | Molecular Sequence Data |
9 | Models, Theoretical |
9 | Host-Pathogen Interactions |
9 | Disease Transmission, Infectious |
9 | Civil Defense |
9 | Cell Line |
9 | Antigens, Viral |
9 | Age Factors |
8 | Swine |
8 | Ritonavir |
8 | Respiration, Artificial |
8 | Quarantine |
8 | Lopinavir |
8 | Information Dissemination |
8 | Health Planning |
8 | Dyspnea |
8 | Disease Progression |
8 | Diagnosis, Differential |
8 | Biomedical Research |
7 | Viruses |
7 | United Kingdom |
7 | Structure-Activity Relationship |
7 | Recombinant Proteins |
7 | Receptors, Virus |
7 | Protein Structure, Tertiary |
7 | Protein Binding |
7 | Prevalence |
7 | Pregnancy |
7 | Peptides |
7 | Murine hepatitis virus |
7 | Mortality |
7 | Membrane Glycoproteins |
7 | Internationality |
7 | Infectious Disease Transmission, Patient-to-Professional |
7 | Hospitalization |
7 | Feces |
7 | Enzyme-Linked Immunosorbent Assay |
7 | Emergencies |
7 | Disaster Planning |
7 | Cross-Sectional Studies |
7 | Communication |
7 | Communicable Disease Control |
7 | Biomarkers |
7 | Australia |
7 | Asymptomatic Infections |
7 | Antibodies, Monoclonal |
6 | Transmissible gastroenteritis virus |
6 | Species Specificity |
6 | Respiratory Syncytial Virus Infections |
6 | Respiratory Distress Syndrome, Adult |
6 | Public Health Surveillance |
6 | Models, Molecular |
6 | Mental Health Services |
6 | Infectious Disease Incubation Period |
6 | Forecasting |
6 | Drug Design |
6 | Disease Susceptibility |
6 | DNA, Viral |
6 | Cross Infection |
6 | Critical Care |
6 | Coronavirus, Bovine |
6 | Computational Biology |
6 | Cluster Analysis |
6 | Cats |
6 | Base Sequence |
6 | Anxiety |
6 | Algorithms |
6 | Air Travel |
5 | Viral Load |
5 | Vero Cells |
5 | Travel Medicine |
5 | Taiwan |
5 | Swine Diseases |
5 | Sweden |
5 | Surveys and Questionnaires |
5 | Social Conditions |
5 | Respiratory Syncytial Viruses |
5 | Respiratory Insufficiency |
5 | Recombination, Genetic |
5 | Politics |
5 | Personal Protective Equipment |
5 | Paramyxoviridae Infections |
5 | Neutralization Tests |
5 | Models, Statistical |
5 | Mental Health |
5 | Medical History Taking |
5 | Intensive Care Units |
5 | Incidence |
5 | Health Services Accessibility |
5 | Fluorescent Antibody Technique |
5 | Fatigue |
5 | Family Health |
5 | Drugs, Chinese Herbal |
5 | Drug Evaluation, Preclinical |
5 | Drug Discovery |
5 | Dogs |
5 | Diarrhea |
5 | Databases, Genetic |
5 | Critical Illness |
5 | Comorbidity |
5 | Commerce |
5 | Clinical Trials as Topic |
5 | Chlorocebus aethiops |
5 | Bronchoalveolar Lavage Fluid |
5 | Binding Sites |
5 | Bacterial Infections |
5 | Antibodies, Bacterial |
5 | Alanine |
4 | Vulnerable Populations |
4 | Virus Cultivation |
4 | Virulence |
4 | Viral Structural Proteins |
4 | Universities |
4 | Uncertainty |
4 | T-Lymphocytes, Cytotoxic |
4 | Stress, Psychological |
4 | Singapore |
4 | Serologic Tests |
4 | Seroepidemiologic Studies |
4 | Sequence Analysis, Protein |
4 | Seasons |
4 | Science |
4 | Risk |
4 | Respiratory Tract Diseases |
4 | Research |
4 | Reproducibility of Results |
4 | RNA Viruses |
4 | Protein Structure, Secondary |
4 | Poultry Diseases |
4 | Periodicals as Topic |
4 | Patient Care Planning |
4 | Myalgia |
4 | Molecular Dynamics Simulation |
4 | Microscopy, Electron |
4 | Mice, Inbred C57BL |
4 | Mice, Inbred BALB C |
4 | Magnetic Resonance Spectroscopy |
4 | Italy |
4 | Interprofessional Relations |
4 | Infectious bronchitis virus |
4 | Infections |
4 | Immunity |
4 | Hemagglutination Inhibition Tests |
4 | Guidelines as Topic |
4 | Evidence-Based Medicine |
4 | Epitopes |
4 | Epitopes, T-Lymphocyte |
4 | Encephalomyelitis |
4 | Emigration and Immigration |
4 | Drug Repositioning |
4 | Drug Combinations |
4 | Demyelinating Diseases |
4 | Cysteine Endopeptidases |
4 | Colorectal Neoplasms |
4 | Circular Dichroism |
4 | Chloroquine |
4 | Chickens |
4 | Camelus |
4 | Brain |
4 | Basic Reproduction Number |
4 | Antibodies, Neutralizing |
4 | Animals, Newborn |
4 | Age Distribution |
4 | Acute Disease |
4 | Access to Information |
3 | Whole Genome Sequencing |
3 | Virus Physiological Phenomena |
3 | Viral Nonstructural Proteins |
3 | Viral Fusion Proteins |
3 | Vaccines |
3 | Transportation |
3 | Trachea |
3 | Thailand |
3 | State Medicine |
3 | Specimen Handling |
3 | Social Media |
3 | Ships |
3 | Sequence Homology, Nucleic Acid |
3 | Sequence Homology, Amino Acid |
3 | Sequence Analysis, DNA |
3 | Ribonucleotides |
3 | Respiratory System |
3 | Rabbits |
3 | Public Health Practice |
3 | Protein Folding |
3 | Protein Conformation |
3 | Protective Clothing |
3 | Pregnancy Complications, Infectious |
3 | Predictive Value of Tests |
3 | Peptide Fragments |
3 | Orthomyxoviridae |
3 | Open Reading Frames |
3 | Occupational Exposure |
3 | Nucleosides |
3 | Nucleocapsid Proteins |
3 | Nucleic Acid Amplification Techniques |
3 | Mycoplasma Infections |
3 | Molecular Epidemiology |
3 | Molecular Diagnostic Techniques |
3 | Models, Genetic |
3 | Models, Biological |
3 | Middle East |
3 | Metapneumovirus |
3 | Melia azedarach |
3 | Masks |
3 | Macrophages |
3 | Lung Diseases |
3 | Liver |
3 | Laboratories |
3 | Japan |
3 | Internet |
3 | International Cooperation |
3 | Interferon-alpha |
3 | Interferon Type I |
3 | Infectious Disease Transmission, Vertical |
3 | Immunoglobulin G |
3 | Immunity, Innate |
3 | Hygiene |
3 | Host Specificity |
3 | Holidays |
3 | Hemagglutinins, Viral |
3 | Health Policy |
3 | Genes, Viral |
3 | Gene Expression Profiling |
3 | France |
3 | Fluorescent Dyes |
3 | Fatal Outcome |
3 | Evolution, Molecular |
3 | Escherichia coli |
3 | Epithelial Cells |
3 | Epidemiological Monitoring |
3 | Enterocolitis, Pseudomembranous |
3 | Emergency Medical Services |
3 | Drug Therapy, Combination |
3 | Disease Models, Animal |
3 | Cytopathogenic Effect, Viral |
3 | Cytochrome P-450 CYP3A Inhibitors |
3 | Consensus |
3 | Cat Diseases |
3 | Biosensing Techniques |
3 | Bacteria |
3 | Asymptomatic Diseases |
3 | Animals, Wild |
3 | Animal Husbandry |
3 | Angiotensin II |
3 | Africa |
3 | Adaptation, Psychological |
2 | Virus Shedding |
2 | Virus Internalization |
2 | Virus Attachment |
2 | Virology |
2 | Vaccines, Synthetic |
2 | Vaccines, DNA |
2 | Trypsin |
2 | Travel-Related Illness |
2 | Transcription, Genetic |
2 | Tonsillectomy |
2 | Toll-Like Receptor 7 |
2 | Tertiary Care Centers |
2 | Telemedicine |
2 | T-Lymphocytes |
2 | Syndrome |
2 | Switzerland |
2 | Survival Rate |
2 | Substrate Specificity |
2 | Spectrometry, Fluorescence |
2 | Software |
2 | Social Support |
2 | Sleep |
2 | Signal Transduction |
2 | Sex Distribution |
2 | Rural Population |
2 | Rotavirus Infections |
2 | Rodent Diseases |
2 | Rhinovirus |
2 | Respiratory Syncytial Virus, Bovine |
2 | Respiratory Sounds |
2 | Reproduction |
2 | Renin-Angiotensin System |
2 | Reference Standards |
2 | Reagent Kits, Diagnostic |
2 | Random Allocation |
2 | Radiography |
2 | Racism |
2 | RNA Interference |
2 | Public Policy |
2 | Public Health Administration |
2 | Proteome |
2 | Protein Multimerization |
2 | Protease Inhibitors |
2 | Prospective Studies |
2 | Pregnancy Outcome |
2 | Porcine epidemic diarrhea virus |
2 | Polyethylene Glycols |
2 | Plasma |
2 | Picornaviridae Infections |
2 | Pharynx |
2 | Pharyngitis |
2 | Peritonitis |
2 | Patient Safety |
2 | Patient Education as Topic |
2 | Patient Discharge |
2 | Patient Care |
2 | Palatine Tonsil |
2 | Orthomyxoviridae Infections |
2 | Noninvasive Ventilation |
2 | Nictitating Membrane |
2 | New Zealand |
2 | Neural Networks, Computer |
2 | Nervous System Diseases |
2 | Nasopharynx |
2 | Mycoplasma |
2 | Mutation Rate |
2 | Multiplex Polymerase Chain Reaction |
2 | Molecular Structure |
2 | Models, Chemical |
2 | Models, Animal |
2 | Microscopy, Electron, Transmission |
2 | Microbial Viability |
2 | Microbial Sensitivity Tests |
2 | Mice, SCID |
2 | Mice, Knockout |
2 | Membrane Proteins |
2 | Medicine, Chinese Traditional |
2 | Mass Spectrometry |
2 | Malaria |
2 | Magnetic Resonance Imaging |
2 | Machine Learning |
2 | Macau |
2 | Lymphoid Tissue |
2 | Lung Neoplasms |
2 | Lipid Bilayers |
2 | Leukocyte Count |
2 | Length of Stay |
2 | Latin America |
2 | Kinetics |
2 | Ion Channels |
2 | Intestines |
2 | International Health Regulations |
2 | Interleukin-6 |
2 | Intensive Care Units, Neonatal |
2 | Inpatients |
2 | Influenza A virus |
2 | Inflammation |
2 | Infant, Newborn, Diseases |
2 | Indoles |
2 | India |
2 | Immunotherapy |
2 | Immunoglobulin A |
2 | Immunocompetence |
2 | Immunization |
2 | Immunization, Passive |
2 | Immune Sera |
2 | Hypertrophy |
2 | Hydrophobic and Hydrophilic Interactions |
2 | Housing, Animal |
2 | Hospitals |
2 | Hospitals, Psychiatric |
2 | Histocompatibility Antigens Class I |
2 | High-Throughput Nucleotide Sequencing |
2 | Hepatitis B |
2 | Hepacivirus |
2 | Hematopoietic Stem Cell Transplantation |
2 | Health Workforce |
2 | Health Status |
2 | Health Knowledge, Attitudes, Practice |
2 | HIV-1 |
2 | HIV Infections |
2 | Guinea Pigs |
2 | Germany |
2 | Genomics |
2 | Genetic Vectors |
2 | Genetic Variation |
2 | Genetic Engineering |
2 | Gene Expression Regulation |
2 | Follow-Up Studies |
2 | Feline Infectious Peritonitis |
2 | Feasibility Studies |
2 | Fear |
2 | Faculty |
2 | Eutheria |
2 | European Union |
2 | Escherichia coli Infections |
2 | Equipment and Supplies, Hospital |
2 | Epitopes, B-Lymphocyte |
2 | Environmental Exposure |
2 | Enteritis |
2 | Emergency Service, Hospital |
2 | Editorial Policies |
2 | Dog Diseases |
2 | Dipeptidyl Peptidase 4 |
2 | Developing Countries |
2 | Depression |
2 | Decision Making |
2 | Dairying |
2 | Cytomegalovirus |
2 | Cross Reactions |
2 | Counseling |
2 | Coronavirus, Canine |
2 | Conservation of Natural Resources |
2 | Consensus Sequence |
2 | Coinfection |
2 | Clinical Laboratory Techniques |
2 | Chymotrypsin |
2 | Chronic Disease |
2 | Chromatography, High Pressure Liquid |
2 | Chick Embryo |
2 | Centers for Disease Control and Prevention, U.S. |
2 | Cells, Cultured |
2 | Cell Survival |
2 | Catalytic Domain |
2 | Catalysis |
2 | Case-Control Studies |
2 | Canada |
2 | Brazil |
2 | Body Weight |
2 | Blood Chemical Analysis |